Growth Insights on the Global CRISPR/Cas9 Tools Market, 2017

Growth Insights on the Global CRISPR/Cas9 Tools Market, 2017

A Disruptive Technology—Gene-editing Tools for Multiple Applied Industries

RELEASE DATE
31-Oct-2017
REGION
North America
Research Code: K242-01-00-00-00
SKU: LS00274-NA-MR_21036
AvailableYesPDF Download
$3,000.00
In stock
SKU
LS00274-NA-MR_21036
$3,000.00
DownloadLink
ENQUIRE NOW

Description

Since its inception, CRISPR has gained strong traction from the global research community because of its huge potential in diverse applications. Considering CRISPR’s disruptive and game-changing applications, a number of large and small participants have invested in this domain. Along the same line, CRISPR has witnessed a multi-fold uptake in funding from the National Institutes of Health (NIH) and other government agencies. As a result, these investments have led to significant growth in new product and application development, thereby creating new market segments and revenue growth opportunities for existing companies and new entrants.

In 2017, the CRISPR/Cas9 tools market opportunity will likely be about $1.8 to $2 billion. The therapeutics and agriculture segments will contribute the most revenue potential. The market is currently highly fragmented, with a handful of global participants and a large number of application-focused participants operating in their respective segments. Competition in the therapeutics and agriculture domains is highly concentrated, and most market and technology developments have been focused around a few companies. Even large pharmaceutical companies have partnered with these existing participants to source innovation and to support their product development using CRISPR. With the ongoing patent war between the University of California and Broad Institute, this situation will likely remain the same. Frost & Sullivan expects that large pharmaceutical companies will only commit direct investments in this segment after understanding the final outcome of the ongoing patent cases.

The objective of this research study is to consider and analyze all these market developments and present a realistic market landscape. This research publication covers insights on existing and emerging growth opportunities in the CRISPR/Cas9 tools market. The study covers qualitative market insights on various market segments and sub-segments, including agriculture, human therapeutics, research tools, and drug discovery activities. The report identifies existing gaps in product and service offerings of key participants across segments, disruptive technologies, and key market and technology trends. The research study further delves into the market’s competitive landscape and patent licensing landscape analysis.

Key Questions This Study Will Answer:
•     Who are the key competitors in the emerging CRISPR/Cas9 market, both tools and therapeutics?
•     What are the growth opportunities that companies should pursue now and in the future?
•     To stay relevant, what are the competitive differentiators that companies should employ in an increasingly crowded competitive base?
•     What is the current patent landscape for this domain, and what are the key associated opportunities?
•     What are the key game-changing disruptive technologies that might impact future market development?

Table of Contents

Key Findings

Market Definitions and Other Gene-editing Options

Scope and Segmentation—CRISPR/Cas9 Tools Market

Market Background and Overview

Key Market Drivers

Key Market Restraints

CRISPR/Cas9 Research Funding Growth

CRISPR/Cas9 Tools Market Potential

Growth Opportunity 1—CRISPR Therapeutics Development

CRISPR Therapeutics—Collaboration and Partnerships

Competitive Ecosystem of the CRISPR Therapeutics Segment

Potential Opportunities

Growth Opportunity 2—Animal and Disease Model Development

Product Portfolio Benchmarking and Gap Analysis

Key Market Opportunities

Growth Opportunity 3—CRISPR Research and Design Tools

Product Portfolio Benchmarking and Gap Analysis

Key Market Opportunities

Growth Opportunity 4—Drug Compound and Target Screening

Growth Opportunity 5—Agriculture and Nutritional Healthcare Products

CRISPR in Agriculture—Current Status and Future Applications

Growth Opportunity Matrix—Key Opportunities and Business Impact

Market Trends

Market Impact of Top Trends

Competitive Environment

Key Market Companies

Companies to Action

Competitor List

Patent Licensing—Current Landscape

Potential Game-changing Disruptive Technologies

Strategic Imperatives for CRISPR/Cas9 Companies

Legal Disclaimer

List of Figures
  • 1. CRISPR/Cas9 Tools Market: Key Market Drivers, Global, 2018–2021
  • 2. CRISPR/Cas9 Tools Market: Key Market Restraints, Global, 2018–2021
  • 3. CRISPR/Cas9 Tools Market: Competitive Structure, Global, 2017
  • 4. CRISPR/Cas9 Tools Market: Competitor List, Global, 2017
List of Charts
  • 1. CRISPR/Cas9 Tools Market: NIH—Funding of Related Projects, US, 2012–2016
  • 2. CRISPR/Cas9 Tools Market: Growth Opportunity Matrix, Global, 2018–2021
  • 3. CRISPR/Cas9 Tools Market: Impact of Top Trends, Global, 2018–2021
Related Research
Since its inception, CRISPR has gained strong traction from the global research community because of its huge potential in diverse applications. Considering CRISPR’s disruptive and game-changing applications, a number of large and small participants have invested in this domain. Along the same line, CRISPR has witnessed a multi-fold uptake in funding from the National Institutes of Health (NIH) and other government agencies. As a result, these investments have led to significant growth in new product and application development, thereby creating new market segments and revenue growth opportunities for existing companies and new entrants. In 2017, the CRISPR/Cas9 tools market opportunity will likely be about $1.8 to $2 billion. The therapeutics and agriculture segments will contribute the most revenue potential. The market is currently highly fragmented, with a handful of global participants and a large number of application-focused participants operating in their respective segments. Competition in the therapeutics and agriculture domains is highly concentrated, and most market and technology developments have been focused around a few companies. Even large pharmaceutical companies have partnered with these existing participants to source innovation and to support their product development using CRISPR. With the ongoing patent war between the University of California and Broad Institute, this situation will likely remain the same. Frost & Sullivan expects that large pharmaceutical companies will only commit direct investments in this segment after understanding the final outcome of the ongoing patent cases. The objective of this research study is to consider and analyze all these market developments and present a realistic market landscape. This research publication covers insights on existing and emerging growth opportunities in the CRISPR/Cas9 tools market. The study covers qualitative market insights on various market segments and sub-segments, including agricu
More Information
No Index No
Podcast No
Table of Contents | Executive Summary~ || Key Findings~ || Market Definitions and Other Gene-editing Options~ || Scope and Segmentation—CRISPR/Cas9 Tools Market~ || Market Background and Overview~ | Growth Drivers and Opportunities~ || Key Market Drivers~ || Key Market Restraints~ || CRISPR/Cas9 Research Funding Growth~ || CRISPR/Cas9 Tools Market Potential~ | Growth Opportunities~ || Growth Opportunity 1—CRISPR Therapeutics Development~ || CRISPR Therapeutics—Collaboration and Partnerships~ || Competitive Ecosystem of the CRISPR Therapeutics Segment~ || Potential Opportunities~ || Growth Opportunity 2—Animal and Disease Model Development~ || Product Portfolio Benchmarking and Gap Analysis~ || Key Market Opportunities~ || Growth Opportunity 3—CRISPR Research and Design Tools~ || Product Portfolio Benchmarking and Gap Analysis~ || Key Market Opportunities~ || Growth Opportunity 4—Drug Compound and Target Screening~ || Growth Opportunity 5—Agriculture and Nutritional Healthcare Products~ || CRISPR in Agriculture—Current Status and Future Applications~ | Growth Opportunities Matrix~ || Growth Opportunity Matrix—Key Opportunities and Business Impact~ | Key Market Trends and Impact Analysis~ || Market Trends~ || Market Impact of Top Trends~ | Competitive Analysis~ || Competitive Environment~ || Key Market Companies~ || Companies to Action~ || Competitor List~ | Patient Licensing Landscape~ || Patent Licensing—Current Landscape~ | Potential Game-changing Disruptive Technologies~ || Potential Game-changing Disruptive Technologies~ | Strategic Imperatives~ || Strategic Imperatives for CRISPR/Cas9 Companies~ || Legal Disclaimer~ | The Frost & Sullivan Story~
List of Charts and Figures 1. CRISPR/Cas9 Tools Market: Key Market Drivers, Global, 2018–2021~ 2. CRISPR/Cas9 Tools Market: Key Market Restraints, Global, 2018–2021~ 3. CRISPR/Cas9 Tools Market: Competitive Structure, Global, 2017~ 4. CRISPR/Cas9 Tools Market: Competitor List, Global, 2017~| 1. CRISPR/Cas9 Tools Market: NIH—Funding of Related Projects, US, 2012–2016~ 2. CRISPR/Cas9 Tools Market: Growth Opportunity Matrix, Global, 2018–2021~ 3. CRISPR/Cas9 Tools Market: Impact of Top Trends, Global, 2018–2021~
Author Piyush Bansal
WIP Number K242-01-00-00-00
Keyword 1 CRISPR
Keyword 2 Cas9
Keyword 3 CRISPR/Cas9
Is Prebook No